Medpace Holdings, Inc. (MEDP)
Data as of , from SEC Form 4 filings.
See up to 3 months of MEDP. The 7-day demo opens the 1M and 3M ranges and puts MEDP on your watchlist.
Start 7-day demoLatest MEDP insider trades
About Medpace Holdings, Inc. (MEDP)
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
- CINCINNATI, OH
- 6,500
- 2016
- XNAS
MEDP Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 31 | 336,935 | $208.47M |
| Option exercise | 22 | 47,590 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MEDP insider transactions (Form 4)
5797 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Cornelius P. McCarthy III - Director | Grant or award | Stock Option (Right to Buy) | 1,110 | $0.00 | - | |
| Robert O. Kraft - Director | Grant or award | Stock Option (Right to Buy) | 1,110 | $0.00 | - | |
 Femida H. Gwadry-Sridhar - Director | Grant or award | Stock Option (Right to Buy) | 1,110 | $0.00 | - | |
| Fred B. Davenport Jr. - Director | Grant or award | Stock Option (Right to Buy) | 1,110 | $0.00 | - | |
| Brian T. Carley - Director | Grant or award | Stock Option (Right to Buy) | 1,110 | $0.00 | - | |
| August J. Troendle - Officer | Grant or award | Employee Stock Option (Right to Buy) | 20,000 | $0.00 | - | |
| August J. Troendle - Officer | Grant or award | Restricted Stock Unit | 10,000 | $0.00 | - | |
| Stephen P. Ewald - Officer | Option exercise | Common Stock | 3,500 | $138.87 | $486K | |
| Stephen P. Ewald - Officer | Option exercise | Employee Stock Option (Right to Buy) | 3,500 | $0.00 | - | |
| Stephen P. Ewald - Officer | Grant or award | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Stephen P. Ewald - Officer | Grant or award | Restricted Stock Unit | 5,000 | $0.00 | - | |
| Susan E. Burwig - Officer | Grant or award | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Susan E. Burwig - Officer | Grant or award | Restricted Stock Unit | 5,000 | $0.00 | - | |
| Kevin M. Brady - Officer | Option exercise | Common Stock | 7,000 | $138.87 | $972K | |
| Kevin M. Brady - Officer | Option exercise | Employee Stock Option (Right to Buy) | 7,000 | $0.00 | - | |
| Kevin M. Brady - Officer | Grant or award | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| Kevin M. Brady - Officer | Grant or award | Restricted Stock Unit | 5,000 | $0.00 | - | |
| Cornelius P. McCarthy III - Director | Option exercise | Common Stock | 29 | - footnote F1 | - | |
| Cornelius P. McCarthy III - Director | Option exercise | Restricted Stock Unit | 29 | $0.00 | - | |
| ||||||
| Robert O. Kraft - Director | Option exercise | Common Stock | 33 | - footnote F1 | - | |
| Robert O. Kraft - Director | Option exercise | Restricted Stock Unit | 33 | $0.00 | - | |
| ||||||
| Brian T. Carley - Director | Option exercise | Common Stock | 36 | - footnote F1 | - | |
| Brian T. Carley - Director | Option exercise | Restricted Stock Unit | 36 | $0.00 | - | |
| ||||||
| Susan E. Burwig - Officer | Option exercise | Common Stock | 12,000 | $166.73 | $2.00M | |
| Susan E. Burwig - Officer | Option exercise | Employee Stock Option (Right to Buy) | 12,000 | $0.00 | - | |
| Jesse J. Geiger - Officer | Option exercise | Common Stock | 31,707 | $138.87 | $4.40M | |
| Jesse J. Geiger - Officer | Open-market sale | Common Stock | 31,707 | $455.30 footnote F1 | $14.44M | |
| Jesse J. Geiger - Officer | Option exercise | Employee Stock Option (Right to Buy) | 31,707 | $0.00 | - | |
| ||||||
| Stephen P. Ewald - Officer | Option exercise | Common Stock | 3,500 | $138.87 | $486K | |
| Stephen P. Ewald - Officer | Option exercise | Employee Stock Option (Right to Buy) | 3,500 | $0.00 | - | |
| Brian T. Carley - Director | Option exercise | Common Stock | 6,472 | $54.99 | $356K | |
| Brian T. Carley - Director | Option exercise | Stock Option (Right to Buy) | 6,472 | $0.00 | - | |
| Susan E. Burwig - Officer | Option exercise | Common Stock | 10,984 | $107.93 | $1.19M | |
| Susan E. Burwig - Officer | Option exercise | Employee Stock Option (Right to Buy) | 10,984 | $0.00 | - | |
| Susan E. Burwig - Officer | Option exercise | Common Stock | 10,000 | $107.93 | $1.08M | |
| Susan E. Burwig - Officer | Option exercise | Employee Stock Option (Right to Buy) | 10,000 | $0.00 | - | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 668 | $590.69 footnote F2 | $395K | |
| ||||||
| August J. Troendle - Officer | Open-market sale | Common Stock | 23,178 | $593.25 footnote F2 | $13.75M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 5,698 | $590.47 footnote F3 | $3.36M | |
| ||||||
| Cornelius P. McCarthy III - Director | Grant or award | Restricted Stock Unit | 113 | $592.46 | $67K | |
| Brian T. Carley - Director | Grant or award | Restricted Stock Unit | 143 | $592.46 | $85K | |
| Robert O. Kraft - Director | Grant or award | Restricted Stock Unit | 130 | $592.46 | $77K | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 41,331 | $606.88 footnote F2 | $25.08M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 15,151 | $593.46 footnote F3 | $8.99M | |
| ||||||
| Susan E. Burwig - Officer | Open-market sale | Common Stock | 20,000 | $609.15 footnote F2 | $12.18M | |
| ||||||
| August J. Troendle - Officer | Open-market sale | Common Stock | 59,025 | $607.78 footnote F2 | $35.87M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 42,392 | $615.52 footnote F3 | $26.09M | |
| ||||||
| Kevin M. Brady - Officer | Option exercise | Common Stock | 3,000 | $166.73 | $500K | |
| Kevin M. Brady - Officer | Open-market sale | Common Stock | 3,000 | $590.35 footnote F2 | $1.77M | |
| Kevin M. Brady - Officer | Gift | Common Stock | 170 | $0.00 | - | |
| Kevin M. Brady - Officer | Option exercise | Employee Stock Option (Right to Buy) | 3,000 | $0.00 | - | |
| ||||||
| August J. Troendle - Officer | Open-market sale | Common Stock | 6,830 | $598.49 footnote F2 | $4.09M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 21,858 | $592.18 footnote F3 | $12.94M | |
| ||||||
| August J. Troendle - Officer | Open-market sale | Common Stock | 23,862 | $592.07 footnote F3 | $14.13M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 7,191 | $590.84 footnote F2 | $4.25M | |
| ||||||
| August J. Troendle - Officer | Open-market sale | Common Stock | 14,747 | $595.26 footnote F2 | $8.78M | |
| August J. Troendle - Officer | Open-market sale | Common Stock | 6,047 | $591.00 footnote F3 | $3.57M | |
| ||||||
Item 2.02, 9.01
Item 5.02
Item 5.03, 5.07, 9.01
Item 2.02, 5.02, 9.01
Recent MEDP Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Kraft Robert O. | Director | 3,858 | $2.38M | View on EDGAR | |
| Brady Kevin M. | Officer | 3,400 | $2.13M | View on EDGAR | |
| DAVENPORT FRED B JR | Director | 7,283 | $4.41M | View on EDGAR |
Stock trades in MEDP disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 David J. TaylorRepublican, OH-02 | Purchase | $1,001 to $15,000 | Member | 13 days | Original filing | ||
| David J. TaylorRepublican, OH-02 | Purchase | $1,001 to $15,000 | Member | 8 days | Original filing | ||
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Sale | $15,001 to $50,000 | Member | 29 days | Original filing | ||
| David J. TaylorRepublican, OH-02 | Purchase | $1,001 to $15,000 | Member | 4 days | Original filing | ||
| David J. TaylorRepublican, OH-02 | Sale | $1,001 to $15,000 | Member | 17 days | Original filing |
House of Representatives Periodic Transaction Reports from 2024. Senate filings are not included yet. The full history of MEDP beside its insider purchases is in the Congress Tracker.
MEDP insider trading FAQ
What is the latest insider trade for MEDP?
Medpace Holdings, Inc. (MEDP) had 25 insider filings in the last 90 days, with the most recent on 2026-10-09. The full record for MEDP runs to 97 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MEDP stock?
No insider purchases of MEDP were filed in the last 90 days.
How many insiders are selling MEDP stock?
31 insider sales of MEDP were filed in the last 90 days, totaling $208.47M.
Where can I see MEDP SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MEDP Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Susan E. Burwig view on EDGAR
- - Cornelius P. McCarthy III view on EDGAR
- - Robert O. Kraft view on EDGAR
- - Brian T. Carley view on EDGAR
- - August J. Troendle view on EDGAR
- - August J. Troendle view on EDGAR
- - August J. Troendle view on EDGAR
- - August J. Troendle view on EDGAR
- - August J. Troendle view on EDGAR
- - August J. Troendle view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where MEDP's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MEDP with a 7-day demo
- MEDP on your watchlist
- Every MEDP Form 4 filing on record
- Up to 3 months of MEDP price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.